FoxM1 negative/low GBM patients also showed significantly longer PFS (Median = 450 days, Range = 114~780 days, p-value = 0.037, Fig 7C, right) than FoxM1 high GBM patients (Median = 360 days, Range = 114~360 days). This evidence concerns the gene FOXM1 and glioblastoma.